C21 · Pharmaceuticals · Global
Phase I immunology clinical trial starts growth rate
Global: -13% in 2025.
- -13% Latest · Global · 2025
- Annual Release cadence
- 2 Records · 1 region · 2025
Verified 27 Sep 2026 · 1 publisher · Next period 2026
The figure
One published observation so far. A chart follows as soon as a second period is published.
Phase I immunology clinical trial starts growth rate
Global, 2025
Every record
2 records · 1 region · 2025. Each period links to its record: the value, its source evidence and original document.
Download this data
Every file carries its provenance: the CSV has a source column per row, and the chart images print the publisher, the licence and this page's address under the drawing. Source: IQVIA. Licence: CC BY 4.0.
Use and publication rights
- View, cite and link: free
Quote any number, cite this page or a single record, and link to it anywhere.
- Copy, chart and republish: free with attribution
The data is published under CC BY 4.0, commercial use included. Credit StatOrigin and the original publisher (IQVIA); the chart files already carry that line.
- The source documents: the publisher's terms
Figures are facts read from the publishers' own documents. The documents themselves, their text and design, stay under each publisher's terms; follow the source links for those.
How this measure is built
- Definition
- Percentage change in Phase I immunology clinical trial starts over a specified period.
- Measure
- One slice of Clinical trial starts ( form: growth, segment: phase 1 immunology ) . Total number of clinical trials initiated during a given period. Region and period are columns on every record, not slices.
- Limitations
- Values are shown as published; StatOrigin does not revise, fill gaps or convert currencies.
- Verification
- Each value, unit, period and place was checked against its source evidence before publication. See the methodology and the corrections process.
Sources · 2 documents
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Global R&D Trends 2026 | IQVIA | — | 1 |
| Global R&D Trends 2026 | IQVIA | — | 1 |
Other slices of clinical trial starts
- Alzheimer's disease drug trial starts 21 clinicaltrials gov registry · by start date · alz
- Antibody-drug conjugate trial starts 21 clinicaltrials gov registry · by start date · adc
- Autoimmune cell therapy and T-cell engager trial starts 21 clinicaltrials gov registry · by start date · autoimmune
- Cardiometabolic RNA and next-generation lipid drug trial starts 21 clinicaltrials gov registry · by start date · rnacv
- GLP-1, incretin multi-agonist and amylin trial starts 21 clinicaltrials gov registry · by start date · glp1
- Gene editing trial starts 21 clinicaltrials gov registry · by start date · gene
- Inflammatory bowel disease drug trial starts 21 clinicaltrials gov registry · by start date · ibd
- KRAS and RAS inhibitor trial starts 21 clinicaltrials gov registry · by start date · kras
- Oncology bispecific antibody trial starts 21 clinicaltrials gov registry · by start date · bsab
- Radioligand therapy trial starts 21 clinicaltrials gov registry · by start date · rlt
- Phase I small molecule clinical trial share 6 phase 1 small molecule
- Large company small molecule share of Phase I clinical trial starts 4 large company phase 1 small molecule
Frequently asked questions
What is the latest phase I immunology clinical trial starts growth rate?
Global: -13% in 2025.
Where does this data come from?
From 2 documents published by IQVIA. Every figure on this page links to its record, which preserves the original source evidence.
How often is it updated?
Annual. The newest published period is 2025; the next release should cover 2026. A new figure appears here once the publisher releases it and it passes verification.
Can I use this data?
Yes. StatOrigin publishes it under CC BY 4.0: you may copy, chart and republish it, including commercially, with attribution to StatOrigin and to the original publisher.
Cite this page
Cite the page as a data set, or open any record to cite one figure: each record carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Phase I immunology clinical trial starts growth rate [Data set]. Retrieved October 28, 2026, from https://statorigin.org/indicators/phase-i-immunology-clinical-trial-starts-growth-rate
"Phase I immunology clinical trial starts growth rate." StatOrigin, 2026, https://statorigin.org/indicators/phase-i-immunology-clinical-trial-starts-growth-rate. Accessed 28 Oct. 2026.
StatOrigin. "Phase I immunology clinical trial starts growth rate." Data set, 2026. Accessed October 28, 2026. https://statorigin.org/indicators/phase-i-immunology-clinical-trial-starts-growth-rate.
@misc{statorigin_phase_i_immunology_clinical_trial_starts_growth_rate_2026, title = {Phase I immunology clinical trial starts growth rate}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/indicators/phase-i-immunology-clinical-trial-starts-growth-rate}, note = {Data set. Accessed 2026-10-28} }